HemoTypeSC

DEVICE2 trials

Sponsors

Silver Lake Research Corporation, University of British Columbia

Conditions

Beta-ThalassemiaDiagnoses DiseaseSickle Cell DiseaseSickle Cell TraitSickle Cell-Beta ThalassemiaSickle Cell-SS Disease

Unknown Phase

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Silver Lake Research CorporationDiagnoses Disease

Start: 2018-08-03End: 2018-12-31Target: 600Updated: 2018-08-08

Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada

CompletedNCT05506358

University of British ColumbiaBeta-Thalassemia, Sickle Cell-Beta Thalassemia, Sickle Cell Disease +2

Start: 2022-09-20End: 2023-03-30Updated: 2024-06-04

Related Papers

Morphology-based screening for sickle cell disease using low-cost automated microscopy and machine learning

npj Digital Public Health2026-08-04

Evaluation of low-cost techniques to detect sickle cell disease and β-thalassemia: an open-label, international, multicentre study.

2025-03-29

Low-Cost Automated Microscopy and Morphology-Based Machine Learning Classification of Sickle Cell Disease and Beta-Thalassemia in Nepal and Canada

Blood2023-11-023 citations